IL161166A0 - Solid pharmaceutical formulation for a piperazine urea derivative - Google Patents

Solid pharmaceutical formulation for a piperazine urea derivative

Info

Publication number: IL161166A0
Authority: IL; Israel
Prior art keywords: pharmaceutical formulation; solid pharmaceutical; urea derivative; piperazine urea; piperazine
Prior art date: 2001-10-18

Application number

IL16116602A

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-18

Filing date

2002-10-07

Publication date

2004-08-31

2002-10-07 Application filed by Schering Ag filed Critical Schering Ag

2004-08-31 Publication of IL161166A0 publication Critical patent/IL161166A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL16116602A 2001-10-18 2002-10-07 Solid pharmaceutical formulation for a piperazine urea derivative IL161166A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10152351A DE10152351B4 (en)	2001-10-18	2001-10-18	Solid drug formulation for a piperazine urea derivative
PCT/EP2002/011229 WO2003035037A1 (en)	2001-10-18	2002-10-07	Solid pharmaceutical formulation for a piperazine urea derivative

Publications (1)

Publication Number	Publication Date
IL161166A0 true IL161166A0 (en)	2004-08-31

Family

ID=7703496

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16116602A IL161166A0 (en)	2001-10-18	2002-10-07	Solid pharmaceutical formulation for a piperazine urea derivative

Country Status (23)

Country	Link
EP (1)	EP1435917A1 (en)
JP (1)	JP2005506365A (en)
KR (1)	KR20040047920A (en)
CN (1)	CN1571660A (en)
AR (1)	AR037111A1 (en)
AU (1)	AU2002333896B2 (en)
BR (1)	BR0213340A (en)
CA (1)	CA2463951A1 (en)
CO (1)	CO5580740A2 (en)
DE (1)	DE10152351B4 (en)
EC (1)	ECSP045108A (en)
HR (1)	HRP20040435A2 (en)
IL (1)	IL161166A0 (en)
MX (1)	MXPA04003522A (en)
NO (1)	NO20042022L (en)
NZ (1)	NZ532287A (en)
PE (1)	PE20030472A1 (en)
PL (1)	PL367987A1 (en)
RS (1)	RS32204A (en)
RU (1)	RU2311172C2 (en)
UY (1)	UY27500A1 (en)
WO (1)	WO2003035037A1 (en)
ZA (1)	ZA200403781B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60222667T2 (en)	2001-06-27	2008-07-17	Smithkline Beecham Corp.	FLUORPYRROLIDINES AS DIPEPTIDYLPEPTIDASE INHIBITORS
EP1749519A1 (en) *	2005-08-05	2007-02-07	Schering Aktiengesellschaft	Dosage form with pH-independent sustained release for active substances with pH-dependent solubility
NZ703464A (en) *	2006-04-26	2016-05-27	Alphapharm Pty Ltd	Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
DE102008047910A1 (en)	2008-09-19	2010-03-25	Molkerei Meggle Wasserburg Gmbh & Co. Kg	Tabletting excipient based on lactose and cellulose
KR101654582B1 (en)	2016-05-12	2016-09-06	그린로드(주)	Conical Shaped Buoyant Polymer Filter and Apparatus for Manufacturing the same and Method for Manufacturing the same and Water Treatment Filter including the same
RU2729223C1 (en) *	2020-05-13	2020-08-05	Мераб Георгиевич Чикобава	Dosage form for amplification of nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207665B1 (en) *	1997-06-12	2001-03-27	Schering Aktiengesellschaft	Piperazine derivatives and their use as anti-inflammatory agents
IL137330A0 (en) *	1998-02-05	2001-07-24	Pfizer Prod Inc	Novel dihydroxyhexanoic acid derivatives
DE60039377D1 (en) *	1999-02-09	2008-08-21	Pfizer Prod Inc	Compositions of basic drugs with improved bioavailability

2001
- 2001-10-18 DE DE10152351A patent/DE10152351B4/en not_active Expired - Fee Related
2002
- 2002-10-07 CN CNA02820512XA patent/CN1571660A/en active Pending
- 2002-10-07 AU AU2002333896A patent/AU2002333896B2/en not_active Ceased
- 2002-10-07 BR BR0213340-7A patent/BR0213340A/en not_active IP Right Cessation
- 2002-10-07 IL IL16116602A patent/IL161166A0/en unknown
- 2002-10-07 WO PCT/EP2002/011229 patent/WO2003035037A1/en not_active Application Discontinuation
- 2002-10-07 EP EP02801884A patent/EP1435917A1/en not_active Withdrawn
- 2002-10-07 JP JP2003537604A patent/JP2005506365A/en active Pending
- 2002-10-07 RS YU32204A patent/RS32204A/en unknown
- 2002-10-07 RU RU2004115328/15A patent/RU2311172C2/en not_active IP Right Cessation
- 2002-10-07 CA CA002463951A patent/CA2463951A1/en not_active Abandoned
- 2002-10-07 MX MXPA04003522A patent/MXPA04003522A/en unknown
- 2002-10-07 KR KR10-2004-7005591A patent/KR20040047920A/en not_active Application Discontinuation
- 2002-10-07 NZ NZ532287A patent/NZ532287A/en unknown
- 2002-10-07 PL PL02367987A patent/PL367987A1/en not_active Application Discontinuation
- 2002-10-17 UY UY27500A patent/UY27500A1/en not_active Application Discontinuation
- 2002-10-17 PE PE2002001027A patent/PE20030472A1/en not_active Application Discontinuation
- 2002-10-18 AR ARP020103929A patent/AR037111A1/en unknown
2004
- 2004-05-13 CO CO04044345A patent/CO5580740A2/en not_active Application Discontinuation
- 2004-05-14 NO NO20042022A patent/NO20042022L/en not_active Application Discontinuation
- 2004-05-17 HR HR20040435A patent/HRP20040435A2/en not_active Application Discontinuation
- 2004-05-17 EC EC2004005108A patent/ECSP045108A/en unknown
- 2004-05-17 ZA ZA200403781A patent/ZA200403781B/en unknown

Also Published As

Publication number	Publication date
CO5580740A2 (en)	2005-11-30
HRP20040435A2 (en)	2005-06-30
DE10152351B4 (en)	2005-09-22
KR20040047920A (en)	2004-06-05
NZ532287A (en)	2007-04-27
NO20042022L (en)	2004-05-14
RS32204A (en)	2006-10-27
ECSP045108A (en)	2004-06-28
RU2311172C2 (en)	2007-11-27
WO2003035037A1 (en)	2003-05-01
DE10152351A1 (en)	2003-05-08
RU2004115328A (en)	2005-06-10
CN1571660A (en)	2005-01-26
JP2005506365A (en)	2005-03-03
PE20030472A1 (en)	2003-06-16
BR0213340A (en)	2004-10-05
EP1435917A1 (en)	2004-07-14
UY27500A1 (en)	2003-06-30
ZA200403781B (en)	2004-11-29
CA2463951A1 (en)	2003-05-01
MXPA04003522A (en)	2004-07-23
AR037111A1 (en)	2004-10-20
AU2002333896A2 (en)	2003-05-06
PL367987A1 (en)	2005-03-21
AU2002333896B2 (en)	2007-07-26

Publication	Publication Date	Title
IL221199A (en)	2016-04-21	Pharmaceutical formulation comprising a scent
IL148357A0 (en)	2002-09-12	Pharmaceutical compositions containing a benzamide derivative
PL364223A1 (en)	2004-12-13	Pharmaceutical salts
IL148406A0 (en)	2002-09-12	Pharmaceutical tramadol salts
IL156716A0 (en)	2004-01-04	Pharmaceutical formulation
FIU20000164U0 (en)	2000-04-11	A new pharmaceutical formulation
GB0118689D0 (en)	2001-09-19	Pharmaceutical formulation
HK1045465A1 (en)	2002-11-29	A pharmaceutical formulation comprising megalatranand its prodrug
HUP0303948A2 (en)	2004-04-28	Solid orally-dispersible pharmaceutical formulation
GB0101227D0 (en)	2001-02-28	Pharmaceutical compounds
GB0101225D0 (en)	2001-02-28	Pharmaceutical compounds
GB0031084D0 (en)	2001-01-31	Pharmaceutical compounds
IL148169A0 (en)	2002-09-12	Pharmaceutical compositions containing a benzamide derivative
IL161166A0 (en)	2004-08-31	Solid pharmaceutical formulation for a piperazine urea derivative
AU2002333896A1 (en)	2003-07-03	Solid pharmaceutical formulation for a piperazine urea derivative
GB0019272D0 (en)	2000-09-27	Pharmaceutical compounds
HK1068277A1 (en)	2005-04-29	Pharmaceutical compositions comprising chelidonineor derivatives thereof
GB0024318D0 (en)	2000-11-15	Pharmaceutical compounds
AU2002342940A8 (en)	2003-06-10	New pharmaceutical compounds
GB0005366D0 (en)	2000-04-26	Pharmaceutical compounds
HRP20040757A2 (en)	2004-12-31	A stable pharmaceutical formulation comprising torsemide modification ii
GB0014849D0 (en)	2000-08-09	Pharmaceutical aerosol formulation
GB0104749D0 (en)	2001-04-18	Pharmaceutical formulation
GB0106018D0 (en)	2001-05-02	Pharmaceutical aerosol formulation
GB0128335D0 (en)	2002-01-16	Pharmaceutical aerosol formulation